Vance Thompson Vision - ND
Welcome,         Profile    Billing    Logout  
 1 Trial 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chu, Ralph Y
NCT04747834: Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery

Completed
N/A
100
US
MICOR-304
Carl Zeiss Meditec, Inc., Carl Zeiss Meditec Cataract Technology, Inc.
Cataract
01/22
01/22
NCT06264232: AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal

Recruiting
N/A
286
US
Cataract Surgery
Carl Zeiss Meditec, Inc., ORA, Inc.
Cataract Senile
12/25
05/26
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
N/A
200
US
Corneal Collagen Cross-linking
Glaukos Corporation
Corneal Ectasia
02/26
02/26
Greenwood, Michael
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting
3
528
US
MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet
Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex
Cataract
12/24
01/25
NCT04433702: Effect of Negative Pressure on Pattern Electroretinography Readings

Withdrawn
N/A
10
US
Mercury™ Multi-Pressure Dial (MPD) Experimental Goggle, Mercury™ Multi-Pressure Dial (MPD) Placebo Goggle
Vance Thompson Vision
Glaucoma, Open Angle, Low Risk, Ocular Hypertension, Glaucoma Suspect
12/20
12/20
TrIPLe, NCT04545073: Outcomes of a Trifocal IOL in Post-refractive Patients

Recruiting
N/A
200
US
PanOptix
Vance Thompson Vision ND
Refractive Errors
03/21
05/21
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
N/A
200
US
Corneal Collagen Cross-linking
Glaukos Corporation
Corneal Ectasia
02/26
02/26
Callaghan, Angela
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting
3
528
US
MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet
Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex
Cataract
12/24
01/25
Thiede, Sarah
RANK, NCT05082974: Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)

Completed
3
40
US
OC-01 (varenicline 0.6mg/ml) nasal spray, Placebo (vehicle) nasal spray
Vance Thompson Vision ND
Dry Eye Disease
08/22
08/22
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting
3
528
US
MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet
Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex
Cataract
12/24
01/25
TrIPLe, NCT04545073: Outcomes of a Trifocal IOL in Post-refractive Patients

Recruiting
N/A
200
US
PanOptix
Vance Thompson Vision ND
Refractive Errors
03/21
05/21
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
N/A
200
US
Corneal Collagen Cross-linking
Glaukos Corporation
Corneal Ectasia
02/26
02/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chu, Ralph Y
NCT04747834: Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery

Completed
N/A
100
US
MICOR-304
Carl Zeiss Meditec, Inc., Carl Zeiss Meditec Cataract Technology, Inc.
Cataract
01/22
01/22
NCT06264232: AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal

Recruiting
N/A
286
US
Cataract Surgery
Carl Zeiss Meditec, Inc., ORA, Inc.
Cataract Senile
12/25
05/26
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
N/A
200
US
Corneal Collagen Cross-linking
Glaukos Corporation
Corneal Ectasia
02/26
02/26
Greenwood, Michael
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting
3
528
US
MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet
Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex
Cataract
12/24
01/25
NCT04433702: Effect of Negative Pressure on Pattern Electroretinography Readings

Withdrawn
N/A
10
US
Mercury™ Multi-Pressure Dial (MPD) Experimental Goggle, Mercury™ Multi-Pressure Dial (MPD) Placebo Goggle
Vance Thompson Vision
Glaucoma, Open Angle, Low Risk, Ocular Hypertension, Glaucoma Suspect
12/20
12/20
TrIPLe, NCT04545073: Outcomes of a Trifocal IOL in Post-refractive Patients

Recruiting
N/A
200
US
PanOptix
Vance Thompson Vision ND
Refractive Errors
03/21
05/21
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
N/A
200
US
Corneal Collagen Cross-linking
Glaukos Corporation
Corneal Ectasia
02/26
02/26
Callaghan, Angela
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting
3
528
US
MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet
Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex
Cataract
12/24
01/25
Thiede, Sarah
RANK, NCT05082974: Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)

Completed
3
40
US
OC-01 (varenicline 0.6mg/ml) nasal spray, Placebo (vehicle) nasal spray
Vance Thompson Vision ND
Dry Eye Disease
08/22
08/22
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting
3
528
US
MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet
Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex
Cataract
12/24
01/25
TrIPLe, NCT04545073: Outcomes of a Trifocal IOL in Post-refractive Patients

Recruiting
N/A
200
US
PanOptix
Vance Thompson Vision ND
Refractive Errors
03/21
05/21
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
N/A
200
US
Corneal Collagen Cross-linking
Glaukos Corporation
Corneal Ectasia
02/26
02/26

Download Options